Lifestyle factors associated with survival after colorectal cancer diagnosis

por Boyle, T, Fritschi, L, Platell, C, Heyworth, J
Publicado 2013

Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients

por Morris, M, Platell, C, Fritschi, L, Iacopetta, B
Publicado 2007

General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial

por Wattchow, D A, Weller, D P, Esterman, A, Pilotto, L S, McGorm, K, Hammett, Z, Platell, C, Silagy, C
Publicado 2006

Low stromal Foxp3(+) regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer

por McCoy, M J, Hemmings, C, Miller, T J, Austin, S J, Bulsara, M K, Zeps, N, Nowak, A K, Lake, R A, Platell, C F
Publicado 2015

Australasian ACPGBI risk prediction model for 30‐day mortality after colorectal cancer surgery

por Wilkins, S., Oliva, K., Chowdhury, E., Ruggiero, B., Bennett, A., Andrews, E. J., Dent, O., Chapuis, P., Platell, C., Reid, C. M., McMurrick, P. J.
Publicado 2020